Overview of Bleeding Disorders in Adolescent Females with Menorrhagia
Abstract Women bleed with menses, during childbirth, and after childbirth. Women are more likely to manifest a bleeding disorder as they have more opportunities to experience bleeding challenges in their lifetime. Bleeding disorders such as hemophilia and von Willebrand disease affect 2.5–3 million...
Gespeichert in:
Veröffentlicht in: | Journal of pediatric & adolescent gynecology 2010-12, Vol.23 (6), p.S15-S21 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | S21 |
---|---|
container_issue | 6 |
container_start_page | S15 |
container_title | Journal of pediatric & adolescent gynecology |
container_volume | 23 |
creator | Ahuja, Sanjay P., MD, MS Hertweck, S. Paige, MD |
description | Abstract Women bleed with menses, during childbirth, and after childbirth. Women are more likely to manifest a bleeding disorder as they have more opportunities to experience bleeding challenges in their lifetime. Bleeding disorders such as hemophilia and von Willebrand disease affect 2.5–3 million American women. The most common inherited bleeding disorder in the population is von Willebrand disease with an estimated prevalence of 1–2%. von Willebrand factor (vWF) is required to adhere platelets to exposed subendothelium and protects factor VIII from proteolysis in the circulation.1 The prevalence of vWF rises in studies involving women with menorrhagia, with estimates ranging as high as 10–20% in white women, and 1–2% among African American women.2 Other bleeding disorders seen in adolescents with menorrhagia are disorders of inherited platelet dysfunction, clotting factor deficiencies, thrombocytopenia, and disorders of the fibrinolytic pathway. Not only are women more likely to present early in their life with a bleeding disorder, they are also more likely to have other gynecologic manifestations as a result of these disorders. This article presents an overview of the problem and touches upon the different management strategies available. |
doi_str_mv | 10.1016/j.jpag.2010.08.006 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_810239000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1083318810002500</els_id><sourcerecordid>810239000</sourcerecordid><originalsourceid>FETCH-LOGICAL-c410t-7777816cae0e02c7fb66b83126f5339051ace33a960d5a3c85310dc049b311c03</originalsourceid><addsrcrecordid>eNp9kTFPwzAQhS0EolD4AwwoG1PK2W4SR0JIUCgggRiA2XKcS3FI42InVPx7HBUYGPDik_Xek993hBxRmFCg6Wk9qVdqMWEQHkBMANItskdFxuMp52w7zCB4zKkQI7LvfQ0AWZKKXTJikPOpyPkeuX78QPdhcB3ZKrpsEEvTLqIr460r0fnItNFFaRv0GtsumuNShTlam-41esDWOveqFkYdkJ1KNR4Pv-8xeZlfP89u4_vHm7vZxX2spxS6OAtH0FQrBASms6pI00JwytIq4TyHhCqNnKs8hTJRXIuEUyg1TPOCU6qBj8nJJnfl7HuPvpNLE37WNKpF23spKLCQA4OSbZTaWe8dVnLlzFK5T0lBDvRkLQd6cqAnQchAL5iOv-P7Yonlr-UHVxCcbQQYSgZqTnptsNWBmkPdydKa__PP_9h1Y1qjVfOGn-hr27s24JNUeiZBPg37G9ZHQyOWhFZfg-aTxQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>810239000</pqid></control><display><type>article</type><title>Overview of Bleeding Disorders in Adolescent Females with Menorrhagia</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Ahuja, Sanjay P., MD, MS ; Hertweck, S. Paige, MD</creator><creatorcontrib>Ahuja, Sanjay P., MD, MS ; Hertweck, S. Paige, MD</creatorcontrib><description>Abstract Women bleed with menses, during childbirth, and after childbirth. Women are more likely to manifest a bleeding disorder as they have more opportunities to experience bleeding challenges in their lifetime. Bleeding disorders such as hemophilia and von Willebrand disease affect 2.5–3 million American women. The most common inherited bleeding disorder in the population is von Willebrand disease with an estimated prevalence of 1–2%. von Willebrand factor (vWF) is required to adhere platelets to exposed subendothelium and protects factor VIII from proteolysis in the circulation.1 The prevalence of vWF rises in studies involving women with menorrhagia, with estimates ranging as high as 10–20% in white women, and 1–2% among African American women.2 Other bleeding disorders seen in adolescents with menorrhagia are disorders of inherited platelet dysfunction, clotting factor deficiencies, thrombocytopenia, and disorders of the fibrinolytic pathway. Not only are women more likely to present early in their life with a bleeding disorder, they are also more likely to have other gynecologic manifestations as a result of these disorders. This article presents an overview of the problem and touches upon the different management strategies available.</description><identifier>ISSN: 1083-3188</identifier><identifier>EISSN: 1873-4332</identifier><identifier>DOI: 10.1016/j.jpag.2010.08.006</identifier><identifier>PMID: 20934893</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adolescent ; Antifibrinolytic Agents - therapeutic use ; bleeding disorders ; Blood Coagulation Disorders, Inherited - complications ; Blood Coagulation Disorders, Inherited - epidemiology ; Contraceptives, Oral - therapeutic use ; DDAVP ; Endometriosis - complications ; Female ; Hemorrhagic Disorders - complications ; Hemorrhagic Disorders - epidemiology ; Hemostatics - therapeutic use ; Humans ; Intrauterine Devices, Medicated ; Levonorgestrel - therapeutic use ; Menorrhagia ; Menorrhagia - diagnosis ; Menorrhagia - drug therapy ; Menorrhagia - etiology ; Menorrhagia - surgery ; Obstetrics and Gynecology ; oral contraceptives ; Ovarian Cysts - complications ; Pediatrics</subject><ispartof>Journal of pediatric & adolescent gynecology, 2010-12, Vol.23 (6), p.S15-S21</ispartof><rights>North American Society for Pediatric and Adolescent Gynecology</rights><rights>2010 North American Society for Pediatric and Adolescent Gynecology</rights><rights>Copyright © 2010 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c410t-7777816cae0e02c7fb66b83126f5339051ace33a960d5a3c85310dc049b311c03</citedby><cites>FETCH-LOGICAL-c410t-7777816cae0e02c7fb66b83126f5339051ace33a960d5a3c85310dc049b311c03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jpag.2010.08.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20934893$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahuja, Sanjay P., MD, MS</creatorcontrib><creatorcontrib>Hertweck, S. Paige, MD</creatorcontrib><title>Overview of Bleeding Disorders in Adolescent Females with Menorrhagia</title><title>Journal of pediatric & adolescent gynecology</title><addtitle>J Pediatr Adolesc Gynecol</addtitle><description>Abstract Women bleed with menses, during childbirth, and after childbirth. Women are more likely to manifest a bleeding disorder as they have more opportunities to experience bleeding challenges in their lifetime. Bleeding disorders such as hemophilia and von Willebrand disease affect 2.5–3 million American women. The most common inherited bleeding disorder in the population is von Willebrand disease with an estimated prevalence of 1–2%. von Willebrand factor (vWF) is required to adhere platelets to exposed subendothelium and protects factor VIII from proteolysis in the circulation.1 The prevalence of vWF rises in studies involving women with menorrhagia, with estimates ranging as high as 10–20% in white women, and 1–2% among African American women.2 Other bleeding disorders seen in adolescents with menorrhagia are disorders of inherited platelet dysfunction, clotting factor deficiencies, thrombocytopenia, and disorders of the fibrinolytic pathway. Not only are women more likely to present early in their life with a bleeding disorder, they are also more likely to have other gynecologic manifestations as a result of these disorders. This article presents an overview of the problem and touches upon the different management strategies available.</description><subject>Adolescent</subject><subject>Antifibrinolytic Agents - therapeutic use</subject><subject>bleeding disorders</subject><subject>Blood Coagulation Disorders, Inherited - complications</subject><subject>Blood Coagulation Disorders, Inherited - epidemiology</subject><subject>Contraceptives, Oral - therapeutic use</subject><subject>DDAVP</subject><subject>Endometriosis - complications</subject><subject>Female</subject><subject>Hemorrhagic Disorders - complications</subject><subject>Hemorrhagic Disorders - epidemiology</subject><subject>Hemostatics - therapeutic use</subject><subject>Humans</subject><subject>Intrauterine Devices, Medicated</subject><subject>Levonorgestrel - therapeutic use</subject><subject>Menorrhagia</subject><subject>Menorrhagia - diagnosis</subject><subject>Menorrhagia - drug therapy</subject><subject>Menorrhagia - etiology</subject><subject>Menorrhagia - surgery</subject><subject>Obstetrics and Gynecology</subject><subject>oral contraceptives</subject><subject>Ovarian Cysts - complications</subject><subject>Pediatrics</subject><issn>1083-3188</issn><issn>1873-4332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kTFPwzAQhS0EolD4AwwoG1PK2W4SR0JIUCgggRiA2XKcS3FI42InVPx7HBUYGPDik_Xek993hBxRmFCg6Wk9qVdqMWEQHkBMANItskdFxuMp52w7zCB4zKkQI7LvfQ0AWZKKXTJikPOpyPkeuX78QPdhcB3ZKrpsEEvTLqIr460r0fnItNFFaRv0GtsumuNShTlam-41esDWOveqFkYdkJ1KNR4Pv-8xeZlfP89u4_vHm7vZxX2spxS6OAtH0FQrBASms6pI00JwytIq4TyHhCqNnKs8hTJRXIuEUyg1TPOCU6qBj8nJJnfl7HuPvpNLE37WNKpF23spKLCQA4OSbZTaWe8dVnLlzFK5T0lBDvRkLQd6cqAnQchAL5iOv-P7Yonlr-UHVxCcbQQYSgZqTnptsNWBmkPdydKa__PP_9h1Y1qjVfOGn-hr27s24JNUeiZBPg37G9ZHQyOWhFZfg-aTxQ</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Ahuja, Sanjay P., MD, MS</creator><creator>Hertweck, S. Paige, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101201</creationdate><title>Overview of Bleeding Disorders in Adolescent Females with Menorrhagia</title><author>Ahuja, Sanjay P., MD, MS ; Hertweck, S. Paige, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c410t-7777816cae0e02c7fb66b83126f5339051ace33a960d5a3c85310dc049b311c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adolescent</topic><topic>Antifibrinolytic Agents - therapeutic use</topic><topic>bleeding disorders</topic><topic>Blood Coagulation Disorders, Inherited - complications</topic><topic>Blood Coagulation Disorders, Inherited - epidemiology</topic><topic>Contraceptives, Oral - therapeutic use</topic><topic>DDAVP</topic><topic>Endometriosis - complications</topic><topic>Female</topic><topic>Hemorrhagic Disorders - complications</topic><topic>Hemorrhagic Disorders - epidemiology</topic><topic>Hemostatics - therapeutic use</topic><topic>Humans</topic><topic>Intrauterine Devices, Medicated</topic><topic>Levonorgestrel - therapeutic use</topic><topic>Menorrhagia</topic><topic>Menorrhagia - diagnosis</topic><topic>Menorrhagia - drug therapy</topic><topic>Menorrhagia - etiology</topic><topic>Menorrhagia - surgery</topic><topic>Obstetrics and Gynecology</topic><topic>oral contraceptives</topic><topic>Ovarian Cysts - complications</topic><topic>Pediatrics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahuja, Sanjay P., MD, MS</creatorcontrib><creatorcontrib>Hertweck, S. Paige, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pediatric & adolescent gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahuja, Sanjay P., MD, MS</au><au>Hertweck, S. Paige, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Overview of Bleeding Disorders in Adolescent Females with Menorrhagia</atitle><jtitle>Journal of pediatric & adolescent gynecology</jtitle><addtitle>J Pediatr Adolesc Gynecol</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>23</volume><issue>6</issue><spage>S15</spage><epage>S21</epage><pages>S15-S21</pages><issn>1083-3188</issn><eissn>1873-4332</eissn><abstract>Abstract Women bleed with menses, during childbirth, and after childbirth. Women are more likely to manifest a bleeding disorder as they have more opportunities to experience bleeding challenges in their lifetime. Bleeding disorders such as hemophilia and von Willebrand disease affect 2.5–3 million American women. The most common inherited bleeding disorder in the population is von Willebrand disease with an estimated prevalence of 1–2%. von Willebrand factor (vWF) is required to adhere platelets to exposed subendothelium and protects factor VIII from proteolysis in the circulation.1 The prevalence of vWF rises in studies involving women with menorrhagia, with estimates ranging as high as 10–20% in white women, and 1–2% among African American women.2 Other bleeding disorders seen in adolescents with menorrhagia are disorders of inherited platelet dysfunction, clotting factor deficiencies, thrombocytopenia, and disorders of the fibrinolytic pathway. Not only are women more likely to present early in their life with a bleeding disorder, they are also more likely to have other gynecologic manifestations as a result of these disorders. This article presents an overview of the problem and touches upon the different management strategies available.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20934893</pmid><doi>10.1016/j.jpag.2010.08.006</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1083-3188 |
ispartof | Journal of pediatric & adolescent gynecology, 2010-12, Vol.23 (6), p.S15-S21 |
issn | 1083-3188 1873-4332 |
language | eng |
recordid | cdi_proquest_miscellaneous_810239000 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Adolescent Antifibrinolytic Agents - therapeutic use bleeding disorders Blood Coagulation Disorders, Inherited - complications Blood Coagulation Disorders, Inherited - epidemiology Contraceptives, Oral - therapeutic use DDAVP Endometriosis - complications Female Hemorrhagic Disorders - complications Hemorrhagic Disorders - epidemiology Hemostatics - therapeutic use Humans Intrauterine Devices, Medicated Levonorgestrel - therapeutic use Menorrhagia Menorrhagia - diagnosis Menorrhagia - drug therapy Menorrhagia - etiology Menorrhagia - surgery Obstetrics and Gynecology oral contraceptives Ovarian Cysts - complications Pediatrics |
title | Overview of Bleeding Disorders in Adolescent Females with Menorrhagia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T12%3A01%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Overview%20of%20Bleeding%20Disorders%20in%20Adolescent%20Females%20with%20Menorrhagia&rft.jtitle=Journal%20of%20pediatric%20&%20adolescent%20gynecology&rft.au=Ahuja,%20Sanjay%20P.,%20MD,%20MS&rft.date=2010-12-01&rft.volume=23&rft.issue=6&rft.spage=S15&rft.epage=S21&rft.pages=S15-S21&rft.issn=1083-3188&rft.eissn=1873-4332&rft_id=info:doi/10.1016/j.jpag.2010.08.006&rft_dat=%3Cproquest_cross%3E810239000%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=810239000&rft_id=info:pmid/20934893&rft_els_id=S1083318810002500&rfr_iscdi=true |